Page last updated: 2024-11-07

methylprednisolone acetate and Atrophy

methylprednisolone acetate has been researched along with Atrophy in 2 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beyzadeoglu, T1
Bekler, H1
Gokce, A1
Shields, KG1
Levy, MJ1
Goadsby, PJ1

Other Studies

2 other studies available for methylprednisolone acetate and Atrophy

ArticleYear
Skin and subcutanous fat atrophy after corticosteroid injection for medial epicondylitis.
    Orthopedics, 2011, Volume: 34, Issue:8

    Topics: Adipose Tissue; Adult; Atrophy; Elbow Joint; Female; Glucocorticoids; Humans; Methylprednisolone; Me

2011
Alopecia and cutaneous atrophy after greater occipital nerve infiltration with corticosteroid.
    Neurology, 2004, Dec-14, Volume: 63, Issue:11

    Topics: Adipose Tissue; Adult; Alopecia; Anesthesia, Local; Anesthetics, Local; Atrophy; Female; Headache Di

2004